Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 10, 2024
Differing features of pemphigus in skin of colour versus white skin: A broad-scale cohort study
M Kasperkiewicz, N Elbuluk, B T Ngo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 16, 2021
COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation
M Kasperkiewicz, M Yale, R Strong, et al.
The British Journal of Dermatology
|
March 13, 2010
Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita
M Kasperkiewicz, M Hirose, A Recke, et al.
The British Journal of Dermatology
|
April 9, 2019
Clinical outcomes of patients with pemphigus treated by the same physicians in a public safety net healthcare system vs. a private healthcare system
M Kasperkiewicz, O Lai, A Recke, et al.
Clinical and Experimental Dermatology
|
June 25, 2009
Subacute cutaneous lupus erythematosus associated with terbinafine
M Kasperkiewicz, W Anemüller, I Angelova-Fischer, et al.
The British Journal of Dermatology
|
September 12, 2012
Vitamin D status in patients with bullous pemphigoid
S Tukaj, E Schmidt, A Recke, et al.
The British Journal of Dermatology
|
November 29, 2021
COVID-19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation
M Kasperkiewicz, R Strong, K Mead, et al.
The British Journal of Dermatology
|
September 14, 2011
Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients
M Kasperkiewicz, I Shimanovich, M Meier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 26, 2020
Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic
M Kasperkiewicz, E Schmidt, J A Fairley, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 30, 2020
Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris
N Ernst, M Friedrich, K Bieber, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 10, 2024
Differing features of pemphigus in skin of colour versus white skin: A broad-scale cohort study
M Kasperkiewicz, N Elbuluk, B T Ngo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 16, 2021
COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation
M Kasperkiewicz, M Yale, R Strong, et al.
The British Journal of Dermatology
|
March 13, 2010
Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita
M Kasperkiewicz, M Hirose, A Recke, et al.
The British Journal of Dermatology
|
April 9, 2019
Clinical outcomes of patients with pemphigus treated by the same physicians in a public safety net healthcare system vs. a private healthcare system
M Kasperkiewicz, O Lai, A Recke, et al.
Clinical and Experimental Dermatology
|
June 25, 2009
Subacute cutaneous lupus erythematosus associated with terbinafine
M Kasperkiewicz, W Anemüller, I Angelova-Fischer, et al.
The British Journal of Dermatology
|
September 12, 2012
Vitamin D status in patients with bullous pemphigoid
S Tukaj, E Schmidt, A Recke, et al.
The British Journal of Dermatology
|
November 29, 2021
COVID-19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation
M Kasperkiewicz, R Strong, K Mead, et al.
The British Journal of Dermatology
|
September 14, 2011
Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients
M Kasperkiewicz, I Shimanovich, M Meier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 26, 2020
Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic
M Kasperkiewicz, E Schmidt, J A Fairley, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 30, 2020
Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris
N Ernst, M Friedrich, K Bieber, et al.
Page
of 3